Correction to: Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-020-00263-y, published online 14 August 2020
Since online publication of the article1, a lot of researchers worldwide ask for the datasets used in this study. So we revised the “Data availability” section and added the access to our datasets in this correction as following:
Data availability
The datasets used for the current study are available to download via http://www.microbiome-bigdata.com/project/SARS-CoV-2/.
The original article has been corrected.
Reference
Zhang, F. et al. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals. Signal Transduct. Target Ther. 5, 156 (2020).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, F., Gan, R., Zhen, Z. et al. Correction to: Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals. Sig Transduct Target Ther 6, 161 (2021). https://doi.org/10.1038/s41392-021-00540-4
Published:
DOI: https://doi.org/10.1038/s41392-021-00540-4
